Circadian Deregulation in Multiple Myeloma: BMAL1 / CLOCK Expression Patterns and Diagnostic Performance

May 21, 2026International journal of laboratory hematology

Disrupted Body Clock Gene Patterns and Their Diagnostic Value in Multiple Myeloma

AI simplified

Circadian Biology on OpenScience ↗PubMed ↗DOI ↗OA ↗

Abstract

BMAL1 expression is significantly higher in multiple myeloma patients compared to healthy controls, with an average of 1.12 ± 0.33 versus 0.85 ± 0.33 (p = 0.016).

BMAL1 shows moderate diagnostic performance with an area under the curve (AUC) of 0.729, while CLOCK has a limited AUC of 0.617.
Combining BMAL1 and CLOCK analysis modestly improves diagnostic performance, resulting in an AUC of 0.756.
In multivariate logistic regression, BMAL1 is a strong independent predictor of multiple myeloma (odds ratio = 3343.4, p = 0.0046).
CLOCK demonstrates an inverse association in the same regression model (odds ratio = 0.0037, p = 0.019).
There is a strong correlation between BMAL1 and CLOCK expression in multiple myeloma (correlation coefficient ≈ 0.80), which remains significant after adjustment for various factors.

AI simplified

BACKGROUND: Circadian clock disruption has emerged as a relevant axis in cancer; however, the expression patterns and diagnostic relevance of BMAL1 and CLOCK in multiple myeloma (MM) remain insufficiently defined.

METHODS: BMAL1 and CLOCK mRNA expression was quantified by RT-qPCR in bone marrow samples from 46 newly diagnosed MM patients and 13 healthy controls. Group comparisons, ROC analyses, multivariate logistic regression, partial correlation, and machine-learning models (logistic regression, random forest, and support-vector machine) with stratified 5-fold cross-validation (including class-weighted sensitivity analysis) were performed.

RESULTS: BMAL1 expression was significantly higher in MM than in controls (1.12 ± 0.33 vs. 0.85 ± 0.33, p = 0.016; Cohen's d = 0.83), whereas CLOCK showed no significant univariate difference (p > 0.2). BMAL1 demonstrated moderate diagnostic performance (AUC = 0.729), while CLOCK alone showed limited discrimination (AUC = 0.617). Combined analysis modestly improved performance (AUC = 0.756). In multivariate logistic regression, BMAL1 remained a strong independent predictor of MM (OR = 3343.4, p = 0.0046), whereas CLOCK showed an inverse adjusted association (OR = 0.0037, p = 0.019). BMAL1 and CLOCK expression were strongly correlated in MM (ρ ≈ 0.80), persisting after adjustment for age, ISS stage, and β2-microglobulin (partial r = 0.847, p = 2.2 × 10-13). Among classifiers, the random forest achieved the best performance (AUC = 0.832; AUPRC = 0.952). Specificity was limited across classifiers, indicating that these performance estimates are exploratory and require validation in larger cohorts.

CONCLUSION: MM is characterized by BMAL1 upregulation within a preserved but imbalanced BMAL1/CLOCK axis rather than uniform shifts across circadian genes. Although diagnostic performance is moderate, consistent signals across statistical and machine-learning approaches support an MM-associated circadian expression pattern warranting further validation.

Full Text

Full text is available at the source.

View full text (PDF) ↗View full text (XML) ↗View full text ↗

Circadian Deregulation in Multiple Myeloma: BMAL1 / CLOCK Expression Patterns and Diagnostic Performance

Abstract

Full Text

You found one interesting study. We’ll send the next 7.

what lands in your inbox each week:

Recent issues from the circadian biology brief

Abstract

Full Text

Related papers

You found one interesting study. We’ll send the next 7.

what lands in your inbox each week:

Recent issues from the circadian biology brief